Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. - Wikidata - wikimedia - TriplyDB

Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy.

Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy.

http://www.wikidata.org/entity/Q34345061

about

The 3rd International Meeting on Gene Therapy in Rheumatology and Orthopaedics Osteocytes: master orchestrators of bone A review of mouse critical size defect models in weight bearing bones Functional augmentation of naturally-derived materials for tissue regeneration Gene therapy approaches to regenerating the musculoskeletal system The future of biologic coatings for orthopaedic implants The effect of acoustic radiation force on osteoblasts in cell/hydrogel constructs for bone repair.Nano-ceramic composite scaffolds for bioreactor-based bone engineering.Targeted gene-and-host progenitor cell therapy for nonunion bone fracture repair.Specific biomimetic hydroxyapatite nanotopographies enhance osteoblastic differentiation and bone graft osteointegration.Computed Tomography and Optical Imaging of Osteogenesis-angiogenesis Coupling to Assess Integration of Cranial Bone Autografts and Allografts.Efficacy of colistin-impregnated beads to prevent multidrug-resistant A. baumannii implant-associated osteomyelitis.Amphiphilic degradable polymers for immobilization and sustained delivery of sphingosine 1-phosphate.Orthopedic gene therapy in 2008.Molecular imaging of expression of vascular endothelial growth factor a (VEGF a) in femoral bone grafts transplanted into living mice.Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures.Zoledronate reduces unwanted bone resorption in intercalary bone allografts.Bone regeneration mediated by biomimetic mineralization of a nanofiber matrix.MCP/CCR2 signaling is essential for recruitment of mesenchymal progenitor cells during the early phase of fracture healing.Runx2 overexpression in bone marrow stromal cells accelerates bone formation in critical-sized femoral defects.Activation of bone remodeling after fatigue: differential response to linear microcracks and diffuse damage Effects of antiresorptive agents on osteomyelitis: novel insights into the pathogenesis of osteonecrosis of the jaw.Stromal cell-derived factor 1 regulates the actin organization of chondrocytes and chondrocyte hypertrophy Activation of the Hh pathway in periosteum-derived mesenchymal stem cells induces bone formation in vivo: implication for postnatal bone repair.Elastomeric osteoconductive synthetic scaffolds with acquired osteoinductivity expedite the repair of critical femoral defects in rats.Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model.In vitro evaluation of a double-stranded self-complementary adeno-associated virus type2 vector in bone marrow stromal cells for bone healing.Vascularized bone transplant chimerism mediated by vascular endothelial growth factor.Clinical potential and challenges of using genetically modified cells for articular cartilage repair.Impaired angiogenesis during fracture healing in GPCR kinase 2 interacting protein-1 (GIT1) knock out mice Gene therapy for bone healing.Self-complementary AAV2.5-BMP2-coated femoral allografts mediated superior bone healing versus live autografts in mice with equivalent biomechanics to unfractured femur.Engineering biomaterial systems to enhance viral vector gene delivery.Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice Emulating native periosteum cell population and subsequent paracrine factor production to promote tissue engineered periosteum-mediated allograft healing Toll-like receptor 4 mediates the regenerative effects of bone grafts for calvarial bone repair Synthetic scaffold coating with adeno-associated virus encoding BMP2 to promote endogenous bone repair Cell sources for bone tissue engineering: insights from basic science.Delayed short-course treatment with teriparatide (PTH(1-34)) improves femoral allograft healing by enhancing intramembranous bone formation at the graft-host junction Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering.

P2860

Q24813121-3BAD94C4-1390-4AF1-94BB-91E281FD98D5 Q27022407-22EDAB5F-C564-4D2C-A773-819E38A68062 Q27022463-49621FA9-EA9F-4A3F-89A2-C5B7FC893AE0 Q27026070-B90D913C-EAEB-43C9-9961-42D84E225880 Q28083399-661A3BCA-97BE-4B82-A8B4-04321F1330DB Q28394906-640F8DB7-818F-4B0E-B52C-DF2C11ABDC8F Q30370949-0D5F7724-A075-4CEB-8A6B-FB96C821C0FB Q30411502-561693EB-4181-487A-B534-3270F68A5F3E Q30429011-6E75E795-04FA-44A0-8B0F-38004C413A3F Q30433985-DF3A3674-A29E-4D96-9C71-AC817FDE2AF0 Q30713694-14511076-FF8B-4B28-B460-9222033AC236 Q33608336-33F3F6C2-DB24-4E40-B80C-2BBF0A2BF2C5 Q33700332-14B15270-64C1-4D7B-950C-A0F00E1E933A Q33713231-9EC9FA81-CEFC-4A20-913B-641A35AB153C Q33815441-EA4ECF88-C20B-4B52-8423-B2BABD2464EE Q33835146-BF41D12D-F3C7-422D-B449-8D4DFD74BEA6 Q33989896-EBFB45E0-8E7F-4FA3-8453-C90862ECA054 Q34025790-A7F7F640-4167-46D5-8C43-0CD14DF308FF Q34061791-D2A722D3-3004-45E5-9EBB-E286DE2B0800 Q34083291-064628E0-D5CB-42EA-B6E3-51018044E589 Q34126530-FDABFC9C-D5BD-4CD0-A78E-E954892ED68C Q34162783-68D3373F-B3C5-4A57-B43D-3AFAAC4D79CE Q34279830-78B34ED5-79B0-4F44-AC03-68DA76F3F693 Q34358225-2F91FBD1-1947-459A-8631-F5B477CFE7DE Q34530388-2EA9B5B0-AFF2-4656-9F32-2C5173EC0323 Q34544242-C6212CEA-1C06-4C22-923B-E02BA675FC32 Q34668056-8DAC52E9-51F8-406A-98F6-9E906A8256A0 Q35019998-A303CEF0-FEEB-4A36-86E4-FCE16F745B19 Q35090336-74A302B7-0FDC-4124-8E5E-4947F07C7391 Q35106711-BFBE4CCC-76FC-40AC-9909-8FAE2AE8E6E5 Q35117004-CE0A1D6E-A060-43EB-8823-A00AD0182C33 Q35144378-EB00AFE2-AC5C-4594-8CB1-1091D047E6ED Q35144415-CF22194D-2553-42DB-B96D-8C48C7078DF1 Q35146135-DB6AE717-7FC0-4174-BD8B-CFE09C2ABC29 Q35232478-34052D3C-EBAC-4F94-98DE-16EE2ADBA2AC Q35386678-503CF397-1196-437D-A1DB-69048750AECB Q35566754-375BE7B8-6B19-4872-9921-A85EF978ACAB Q35570031-F46988E3-3D88-403C-9A6D-C818D91D5BDE Q35659476-F468B495-23C2-460C-BDE0-5D7CD542BEB4 Q35924333-0454506C-4720-4F3A-A2C1-C3F8DBE9184F

P2860

Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy.

http://www.wikidata.org/entity/Q34345061

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Remodeling of cortical bone al ...... V-RANKL and VEGF gene therapy.

@ast

Remodeling of cortical bone al ...... V-RANKL and VEGF gene therapy.

@en

Remodeling of cortical bone al ...... V-RANKL and VEGF gene therapy.

@nl

type

label

Remodeling of cortical bone al ...... V-RANKL and VEGF gene therapy.

@ast

Remodeling of cortical bone al ...... V-RANKL and VEGF gene therapy.

@en

Remodeling of cortical bone al ...... V-RANKL and VEGF gene therapy.

@nl

prefLabel

Remodeling of cortical bone al ...... V-RANKL and VEGF gene therapy.

@ast

Remodeling of cortical bone al ...... V-RANKL and VEGF gene therapy.

@en

Remodeling of cortical bone al ...... V-RANKL and VEGF gene therapy.

@nl

P1433

Q34345061-F6E24EB0-33E6-44C5-9099-C28F2EE04093

P1476

Q34345061-13D0A784-AFB5-4D61-9CFD-E04DE73776A9

P2093

Q34345061-07687DD5-7872-4F68-81E8-8AA1CA9223F4

Q34345061-15A23499-C344-4F79-826A-672BAB15F8A8

Q34345061-3799E683-7A8C-4381-8333-931F15CFCE90

Q34345061-4C0DD1AE-9CD9-447F-B19F-DE272DD46CC5

Q34345061-532F8132-86C8-44E9-AAC9-9C623943DF71

Q34345061-644D4C10-26B3-4FED-9E47-803BB5C4F682

Q34345061-66CFD6CD-74EA-4FFE-B160-BAC59A8A85DE

Q34345061-78284907-E68B-4151-B825-BCE6EAC104CC

Q34345061-C23B0F56-6BF4-4EA4-BC7E-0FEBD090234C

Q34345061-D416C3D6-1AB4-4DCA-B3E3-5AA26B72D6F4

P2860

Q34345061-044557ED-CE59-414C-A9EA-2143D4879FB2

Q34345061-0816FA56-6203-4ACC-B8D0-8C9BC0A0826B

Q34345061-0F4BCFD6-23C0-453A-9956-42D28C452A4E

Q34345061-11A32A4B-5A24-46EF-BCEF-A378AF8191A3

Q34345061-18EC07CE-A74C-4E45-A627-80F36DFC076E

Q34345061-2685AFE1-9CB3-47E9-B039-9DEEFC74796B

Q34345061-2AD0AC75-5854-442D-A82D-5FC22793CD19

Q34345061-326B681E-1AE5-4C83-B28E-F4C1F0925C94

Q34345061-39951CA7-461D-4C7A-B494-C51FE73D8F3D

Q34345061-4FB63AE8-9538-408E-BF62-4B4C1F176A65

P2888

Q34345061-EC0E24B0-159D-4771-A576-4435ABD92E88

P304

Q34345061-A1A1243C-B41A-4BD2-A80D-2BCB68136673

P31

Q34345061-9F77588A-8BFB-4A36-A54B-8F933C51091C

P356

Q34345061-5430F1F9-CAF0-4ABF-8F38-B5620314E6A3

P407

Q34345061-85FB76DD-AEA8-48FD-BF0D-0B43A6D54EEC

P433

Q34345061-7367A64E-B8FE-4ACB-A68F-83EF594F0B29

P478

Q34345061-C2783870-2D7B-47C4-8389-5FEAC3A18F78

P50

Q34345061-547E97A4-A210-4A69-B8B2-DCC51E48E623

P577

Q34345061-504E28C4-926D-4DCC-9D4E-3B9271F422B5

P5875

Q34345061-79CC3E7C-AA74-4144-84B8-6C6E591FC96D

P698

Q34345061-03476B9B-A1B5-46D6-9FF9-B416E9818381

P921

Q34345061-A8B4F907-4281-44A9-9794-3CCFC3ACB840

P932

Q34345061-49AEE044-9838-454F-941F-68E8ECF05853

P356

P1433

Nature Medicine

P1476

Remodeling of cortical bone al ...... AV-RANKL and VEGF gene therapy

@en

P2093

Brendan F Boyce

http://www.w3.org/2001/XMLSchema#string

Edward M Schwarz

http://www.w3.org/2001/XMLSchema#string

Hiromu Ito

http://www.w3.org/2001/XMLSchema#string

J Jeffrey Goater

http://www.w3.org/2001/XMLSchema#string

Jonathan Carmouche

http://www.w3.org/2001/XMLSchema#string

Joseph Rabinowitz

http://www.w3.org/2001/XMLSchema#string

Kirill Gromov

http://www.w3.org/2001/XMLSchema#string

Mette Koefoed

http://www.w3.org/2001/XMLSchema#string

Paul T Rubery

http://www.w3.org/2001/XMLSchema#string

Prarop Tiyapatanaputi

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of histocompatibility matching on canine frozen bone allografts

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus

The biology of VEGF and its receptors

Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway

In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis

Inhibition of neuronal phenotype by PTEN in PC12 cells

Osteoclast differentiation and activation

Effect of angiogenic and antiangiogenic compounds on the outgrowth of capillary structures from fetal mouse bone explants.

The biology of bone grafts.

P2888

P304

291-297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM1190

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8020775

http://www.w3.org/2001/XMLSchema#string

P698

15711561

http://www.w3.org/2001/XMLSchema#string

P921

P932

1364464

http://www.w3.org/2001/XMLSchema#string